Continental General Insurance CO Mallinckrodt PLC Transaction History

Continental General Insurance CO

  • $256 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 19, 2024
SELL
N/A
-880,822 Closed
0 $0
Q2 2023

Apr 19, 2024
BUY
N/A
781,154 Added 783.76%
880,822 $1.04 Billion
Q4 2022

Apr 19, 2024
BUY
$0.0 - $15.9 $0 - $1.58 Million
99,668 New
99,668 $783 Million

Others Institutions Holding MNKPF

# of Institutions
1
Shares Held
35K
Call Options Held
0
Put Options Held
0
View Full List

About Mallinckrodt plc

MNKPF Quotes by TradingView
  • Ticker MNKPF
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,170,900
  • Description
  • Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands and Specialty Generics. The company markets branded pharmaceutical products for autoimmune and rare diseases in...
More about MNKPF
Track This Portfolio

Track Continental General Insurance CO Portfolio

Follow Continental General Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental General Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Continental General Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email